Literature DB >> 11277874

Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.

S C Riley1, A H Gibson, R Leask, D J Mauchline, H G Pedersen, E D Watson.   

Abstract

Extensive tissue remodelling is required in equine ovaries for follicle growth and development and also migration of the follicle to the ovulatory fossa, where ovulation occurs. The mechanisms for these processes are largely unexplored. Matrix metalloproteinases (MMPs) and their endogenous tissue inhibitors (TIMPs) are important for control of breakdown of extracellular matrix during tissue remodelling. The aims of this study were to determine the pattern and sites of secretion of the gelatinases MMP-2 and -9 and TIMPs into follicular fluid during follicle development in mare ovaries. The predominant gelatinase detected in follicular fluid was MMP-2, which was present in similar amounts throughout follicular development, as demonstrated by zymography. MMP-9 was also present in follicular fluid and secretion increased significantly (P < 0.05) with development of follicles from < 10 mm to 11-20 mm in diameter. Follicular fluid also contained TIMP-1, TIMP-2, unglycosylated and glycosylated TIMP-3, and TIMP-4, as shown by reverse zymography. The abundance of TIMPs remained largely unchanged during follicle development. MMP-2 and -9 were localized by immunohistochemistry to stromal cells and granulosa and theca cells. TIMP-1, -2, -3 and -4 were present in granulosa and theca cells of the follicle and in stromal cells and also associated with extracellular matrix of the ovarian stromal tissue. The MMPs and TIMPs are likely to be involved in the regulation of the breakdown of extracellular matrix during tissue remodelling for follicle development and migration to the ovulation fossa in mares.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277874

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  8 in total

1.  Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization.

Authors:  Petra Horka; Karin Malickova; Radka Jarosova; Ivana Janatkova; Tomas Zima; Marta Kalousova
Journal:  J Assist Reprod Genet       Date:  2012-09-28       Impact factor: 3.412

2.  Preantral follicle population and distribution in the horse ovary.

Authors:  Kendall A Hyde; Francisco L N Aguiar; Benner G Alves; Kele A Alves; Gustavo D A Gastal; Melba O Gastal; Eduardo L Gastal
Journal:  Reprod Fertil       Date:  2022-04-04

3.  Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle.

Authors:  Katherine L Rosewell; Feixue Li; Muraly Puttabyatappa; James W Akin; Mats Brännström; Thomas E Curry
Journal:  Biol Reprod       Date:  2013-11-21       Impact factor: 4.285

Review 4.  Metalloproteases in gonad formation and ovulation.

Authors:  Yong Zhu
Journal:  Gen Comp Endocrinol       Date:  2021-10-02       Impact factor: 2.822

5.  Matrix metalloproteinases are important for follicular development in normal and miniature pigs.

Authors:  Sang Hwan Kim; Cher Won Kang; Kwan Sik Min; Jong Taek Yoon
Journal:  Biotechnol Lett       Date:  2014-02-22       Impact factor: 2.461

Review 6.  Cytokines and angiogenesis in the corpus luteum.

Authors:  António M Galvão; Graça Ferreira-Dias; Dariusz J Skarzynski
Journal:  Mediators Inflamm       Date:  2013-06-11       Impact factor: 4.711

7.  Matrix metalloproteinase 2 level in human follicular fluid is a reliable marker of human oocyte maturation in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  Wen-Jui Yang; Fon-Chang Liu; Jih-Sheng Hsieh; Ching-Hung Chen; Shun-Yu Hsiao; Chih-Sheng Lin
Journal:  Reprod Biol Endocrinol       Date:  2015-09-04       Impact factor: 5.211

8.  Spatial distribution of preantral follicles in the equine ovary.

Authors:  Benner G Alves; Kele A Alves; Gustavo D A Gastal; Melba O Gastal; José R Figueiredo; Eduardo L Gastal
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.